1. Home
  2. UPLD vs JSPR Comparison

UPLD vs JSPR Comparison

Compare UPLD & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$5.02

Market Cap

17.3M

Sector

Technology

ML Signal

HOLD

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.71

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
JSPR
Founded
2010
2018
Country
United States
United States
Employees
N/A
22
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
14.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
UPLD
JSPR
Price
$5.02
$0.71
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$3.75
$15.50
AVG Volume (30 Days)
62.7K
597.2K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.32
52 Week High
$6.65
$3.52

Technical Indicators

Market Signals
Indicator
UPLD
JSPR
Relative Strength Index (RSI) 70.06 65.26
Support Level $0.62 $0.62
Resistance Level $5.60 $1.02
Average True Range (ATR) 0.39 0.09
MACD -0.07 0.04
Stochastic Oscillator 63.13 87.21

Price Performance

Historical Comparison
UPLD
JSPR

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: